Cadmium: Difference between revisions

From Opasnet
Jump to navigation Jump to search
(Created page with "Category:IEHIAS Category:Exposure Category:Biomarker :''The text on this page is taken from an equivalent page of the IEHIAS-project. Cadmium (Cd)...")
 
mNo edit summary
 
Line 67: Line 67:


Few comparative data exist about the geographical and temporal variations of Cd body burden in Europe. Although a decrease of the Cd body burden has been reported in the general population of some countries, human exposure shows little change compared to the drastic decrease of lead exposure.
Few comparative data exist about the geographical and temporal variations of Cd body burden in Europe. Although a decrease of the Cd body burden has been reported in the general population of some countries, human exposure shows little change compared to the drastic decrease of lead exposure.
==See also==
{{IEHIAS}}

Latest revision as of 19:06, 25 September 2014

The text on this page is taken from an equivalent page of the IEHIAS-project.

Cadmium (Cd), a by-product of zinc production, is a cumulative poison that can cause kidney and bone damage following prolonged exposure in the environment and the industry

Cadmium as a biomarker

Sample collection and storage

Matrix:

Blood and urine (untimed urine sample) are the biological samples commonly used to monitor exposure to Cd.

Kinetics:

  • Inhalation is a main source of exposure in smokers and occupationally exposed persons. For others, food contributes to the majority of the intake
  • Cadmium is mainly stored in the liver and kidneys, and is excreted via urine
  • The biological half-life of Cd is about 100 days in blood and more than 10 years in urine

Sampling conditions:

Blood and urine should be collected in containers free of any metal contamination. Samples can be stored at 4°C or frozen.

Sample measurement

Analytical aspects:

  • atomic absorption spectrometry (AAS) or inductively coupled plasma mass spectrometry (ICP-MS)
  • Sensitivity in 0.01 to 0.1 µg/l

Performance characteristics:

  • Analytical reproducibility is around 1-2 %
  • Inter- and intralaboratory variability around 5-10%

Validation:

Various national and international intercomparison programs are in place, methods are well defined and a wide variety of certified standards and reference materials are available

Confounding factors:

Diuresis is a potential confounder of urinary Cd concentration. Smoking is a confounder for both blood and urinary Cd

Data interpretation

Concentrations reported in literature:

  • Cd in blood of adult non-smoker: < 2 µg/l
  • Cd in blood of adult smokers: < 5 µg/l
  • Cd in blood of children: < 0.5 µg/l
  • Cd in urine of adults: < 2 µg/g creatinin
  • Cd in urine of children: < 0.5 µg/g creatinin

Dose-response/effect relationships:

Cd in blood (µg/l) or in urine (µg/g cr)
< 2 Normal
2-5 Tubular proteinuria unlikely
5-10 Risk of tubular proteinuria in susceptible individuals
> 10 Dose-dependent increase in the risk of tubular proteinuria

Time trend, geographical variation, susceptibel groups:

Few comparative data exist about the geographical and temporal variations of Cd body burden in Europe. Although a decrease of the Cd body burden has been reported in the general population of some countries, human exposure shows little change compared to the drastic decrease of lead exposure.

See also

Integrated Environmental Health Impact Assessment System
IEHIAS is a website developed by two large EU-funded projects Intarese and Heimtsa. The content from the original website was moved to Opasnet.
Topic Pages
Toolkit
Data

Boundaries · Population: age+sex 100m LAU2 Totals Age and gender · ExpoPlatform · Agriculture emissions · Climate · Soil: Degredation · Atlases: Geochemical Urban · SoDa · PVGIS · CORINE 2000 · Biomarkers: AP As BPA BFRs Cd Dioxins DBPs Fluorinated surfactants Pb Organochlorine insecticides OPs Parabens Phthalates PAHs PCBs · Health: Effects Statistics · CARE · IRTAD · Functions: Impact Exposure-response · Monetary values · Morbidity · Mortality: Database

Examples and case studies Defining question: Agriculture Waste Water · Defining stakeholders: Agriculture Waste Water · Engaging stakeholders: Water · Scenarios: Agriculture Crop CAP Crop allocation Energy crop · Scenario examples: Transport Waste SRES-population UVR and Cancer
Models and methods Ind. select · Mindmap · Diagr. tools · Scen. constr. · Focal sum · Land use · Visual. toolbox · SIENA: Simulator Data Description · Mass balance · Matrix · Princ. comp. · ADMS · CAR · CHIMERE · EcoSenseWeb · H2O Quality · EMF loss · Geomorf · UVR models · INDEX · RISK IAQ · CalTOX · PANGEA · dynamiCROP · IndusChemFate · Transport · PBPK Cd · PBTK dioxin · Exp. Response · Impact calc. · Aguila · Protocol elic. · Info value · DST metadata · E & H: Monitoring Frameworks · Integrated monitoring: Concepts Framework Methods Needs
Listings Health impacts of agricultural land use change · Health impacts of regulative policies on use of DBP in consumer products
Guidance System
The concept
Issue framing Formulating scenarios · Scenarios: Prescriptive Descriptive Predictive Probabilistic · Scoping · Building a conceptual model · Causal chain · Other frameworks · Selecting indicators
Design Learning · Accuracy · Complex exposures · Matching exposure and health · Info needs · Vulnerable groups · Values · Variation · Location · Resolution · Zone design · Timeframes · Justice · Screening · Estimation · Elicitation · Delphi · Extrapolation · Transferring results · Temporal extrapolation · Spatial extrapolation · Triangulation · Rapid modelling · Intake fraction · iF reading · Piloting · Example · Piloting data · Protocol development
Execution Causal chain · Contaminant sources · Disaggregation · Contaminant release · Transport and fate · Source attribution · Multimedia models · Exposure · Exposure modelling · Intake fraction · Exposure-to-intake · Internal dose · Exposure-response · Impact analysis · Monetisation · Monetary values · Uncertainty
Appraisal